Skip to main content

Eversept Partners, LP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1697013 NEW YORK, NY

Position in VRDN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$13,951,541
-$41,511,612 QoQ
Shares Held
713,269
-60.0% QoQ
Ownership
0.692%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Eversept Partners, LP holds $674,697,695 across 57 Biotechnology names. VRDN ranks #10 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,951,541 713,269
2025-12-31 $55,463,153 1,782,235
2025-09-30 $41,526,523 1,924,306
2025-06-30 $26,597,495 1,902,539
2025-03-31 $18,571,045 1,377,674
2024-12-31 $14,952,561 779,998
2024-09-30 $15,725,528 691,232
2024-06-30 $7,383,005 567,487
2024-03-31 $2,487,733 142,075
2023-12-31 $2,991,330 137,343
2023-09-30 $6,799,761 443,270
2022-09-30 $9,811,717 478,387
2022-06-30 $5,155,499 445,592
2022-03-31 $2,879,688 155,743
2021-12-31 $3,847,024 194,589
2021-09-30 $2,632,000 160,000